A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Case series:Mesylate Apatinib
Primary outcome(s): R0 resection rate;AE
Study Design: Case series
DISEASE(S): Colorectal Cancer
PROVIDER: 2676351 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA